In this study, we built upon our previous work by focusing on FGFR4 signaling and have uncovered a novel molecular mechanism amplifying FGFR4 activity, further corroborating a tumor-progressive role of dysregulated FGFR4 activity in HCC. The gene discussed is FGFR4; the disease is hepatocellular carcinoma.